CONSOLIDATED STATEMENTS OF OPERATIONS - USD ($) shares in Thousands, $ in Thousands |
12 Months Ended | |
|---|---|---|
Dec. 31, 2021 |
Dec. 31, 2020 |
|
| Operating expenses | ||
| Research and development | $ 5,910 | $ 6,578 |
| General and administrative | 4,533 | 4,330 |
| Total operating expenses | 10,443 | 10,908 |
| Net operating loss | (10,443) | (10,908) |
| Other income | ||
| Interest income | 3 | 26 |
| Total other income | 3 | 26 |
| Net loss | $ (10,440) | $ (10,882) |
| Net loss per share, basic (in dollars per share) | $ (1.55) | $ (2.83) |
| Net loss per share, diluted (in dollars per share) | $ (1.55) | $ (2.83) |
| Weighted average number of common shares outstanding, basic (in shares) | 6,725 | 3,847 |
| Weighted average number of common shares outstanding, diluted (in shares) | 6,725 | 3,847 |